Chiara Porta

8PUBLICATIONS
16CO-AUTHORS
Molecular targetsChemical engineering designInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 30, 2025
Determinants of Response to Immune Checkpoint Blockade in Pleural Mesothelioma: Molecular, Immunological, and Clinical Perspectives.

Martina Delsignore, Gaia Cassinari, Simona Revello

|Jun 24, 2025
The Dual Role of ACE2 in IBD: Balancing SARS-CoV-2 Susceptibility and Gut Homeostasis.

Laura Francesca Pisani, Guglielmo Albertini Petroni, Luca Pastorelli

|Apr 25, 2025
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease.

Laura Francesca Pisani, Gugliemo Albertini Petroni, Giorgia Crespi

|Mar 11, 2023
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma.

Mhd Ouis Al Khatib, Giulia Pinton, Laura Moro

|Feb 15, 2022
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective.

Augusto Bleve, Francesca Maria Consonni, Chiara Porta

|Apr 30, 2021
Inhibition of the Histone Methyltransferase EZH2 Enhances Protumor Monocyte Recruitment in Human Mesothelioma Spheroids.

Silvia Mola, Giulia Pinton, Marco Erreni

Pageof 2

Frequent Collaborators

2 joint publications

Silvia Mola

2 joint publications

Luca Pastorelli

2 joint publications

Laura Francesca Pisani

2 joint publications

Gugliemo Albertini Petroni